Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant MelanomaMark R. Middleton, N. Thatcher, Wolfgang Tilgen et al.|Journal of Clinical Oncology|2000Cited by 1.3k
382 The synthetic long peptide cancer vaccine UV1 in combination with ipilimumab induces a CD4+ Th1 anti-hTERT immune response and an inflammatory tumor microenvironment in patients with melanomaEspen B. Ellingsen, Gustav Gaudernack, Iliana Kerzeli et al.|Regular and Young Investigator Award Abstracts|2021Cited by 0